Gefticip

Gefticip (Gefitinib)

Active IngredientGefitinib
Dosage FormTablet
Available Strength250mg
Manufacturer:Cipla Limited
Packaging30 tablets in 1 strip
Therapeutic useNon-small cell lung cancer
Pack Insert/LeafletYes
Production Capacity1 Million Tablet's/Month

Description

Reviews

There are no reviews yet.

Be the first to review “Gefticip (Gefitinib)”

Your email address will not be published. Required fields are marked *